Food allergy drugs step up to Phase III

Two biotechs have carved out a regulatory pathway for what could become the first FDA-approved preventative peanut allergy therapies.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Authors

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kingwell, K. Food allergy drugs step up to Phase III. Nat Rev Drug Discov 15, 149–150 (2016). https://doi.org/10.1038/nrd.2016.24

Download citation

Further reading

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing